News

Published on 28 Dec 2023 on Zacks via Yahoo Finance

Company News for Dec 28, 2023


Article preview image

Cytokinetics, Incorporated (CYTK) advanced 82.5% as its heart disease drug met late-stage study goals.Tesla (TSLA) shares rose 1.9% following reports from Bloomberg that the company is working on an upgraded version of the Model Y to be manufactured at its Shanghai Gigafactory, scheduled for production commencement in mid-2024.The New York Times Company (NYT) shares gained 2.8% following the company's decision to file a lawsuit against Microsoft Corporation (MSFT) and OpenAI.Shares of Iovance Biotherapeutics, Inc. (IOVA) plunged 18.7% as regulatory authorities imposed a clinical hold on the company's trial of LN-145 for non-small-cell lung cancer.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Microsoft Corporation (MSFT) : Free Stock Analysis Report

NASDAQ.IOVA price evolution
NASDAQ.CYTK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is possibly approaching a major achievement in its bu...

Simply Wall St. via Yahoo Finance 9 Apr 2024

FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study

Iovance Biotherapeutics IOVA announced that the FDA removed the clinical hold placed on the regis...

Zacks via Yahoo Finance 5 Mar 2024

This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag

Hello! This week’s ETF Wrap digs into the jump in biotech funds, as well as an “unusual” trend in...

Market Watch 29 Feb 2024

Iovance's (IOVA) Q4 Earnings & Sales Fall Short of Estimates

Iovance Biotherapeutics, Inc. IOVA incurred a loss of 45 cents per share in fourth-quarter 2023, ...

Zacks via Yahoo Finance 29 Feb 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2023 Earnings Call Transcript

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2023 Earnings Call Transcript February 28, 2024 Io...

Insider Monkey via Yahoo Finance 29 Feb 2024

Iovance Biotherapeutics: Q4 Earnings Snapshot

Iovance Biotherapeutics: Q4 Earnings Snapshot

Washington Post 28 Feb 2024

Iovance Biotherapeutics Inc (IOVA) Reports Q4 and Full Year 2023 Financial Results

Revenue: Reported $0.5 million for Q4 and $1.2 million for the full year 2023, following Proleuki...

GuruFocus.com via Yahoo Finance 28 Feb 2024

Why Iovance (IOVA) Might Surprise This Earnings Season

Investors are always looking for stocks that are poised to beat at earnings season and Iovance Bi...

Zacks via Yahoo Finance 27 Feb 2024

The Zacks Analyst Blog Highlights Moderna, RAPT Therapeutics, Iovance, Sarepta Therapeutics and...

For Immediate Release Chicago, IL – February 23, 2024 – Zacks.com announces the list of stocks fe...

Zacks via Yahoo Finance 23 Feb 2024

13 Best Short Squeeze Stocks To Buy Now

In this piece, we will take a look at the 13 best short squeeze stocks to buy now. If you want to...

Insider Monkey via Yahoo Finance 22 Feb 2024